Prazer Therapeutics
Seoul
About Prazer Therapeutics
Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2025)
- Website: prazertx.com
- Phone: +82 2 6217 1020
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/prazer-therapeutics-92244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.